John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby. Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.
Dr Andrew Davies, Southampton, UK, Professor John Radford, The University of Manchester, UK, Professor Peter Johnson, Southampton University, UK, Dr Karl Peggs, University College Hospital, London, Professor Stephen… read more.
Interview with Professor Joseph Connors, Vancouver, BC, Canada, who spoke for the motion in this key debate at ICML 2015. Interview by Esther Drain.
by Christine Clark: The National Cancer Information Network (NCIN) was established to drive change and improve cancer outcomes. Analyses show large variations in practices and outcomes some of… read more.
Dr Graham Collins from the Oxford Cancer and Haematology Centre, Oxford, UK.
Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.
Professor Graham Jackson, Royal Victoria Infirmary, Newcastle-Upon-Tyne, UK.
UNSW Australia researchers have shown that changing just a single letter of the DNA of human red blood cells in the laboratory increases their production of oxygen-carrying haemoglobin… read more.
by Bruce Sylvester: Researchers from a phase 3, randomized trial of brentuximab vedotin report that adults with hard-to-treat Hodgkin lymphoma treated with brentuximab vedotin immediately after stem cell… read more.
by Bruce Sylvester: A blood test administered between weeks 10 and 14 weeks of pregnancy appears to be a more accurate diagnostic tool for Down syndrome and two… read more.
The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick. The research findings could potentially lead to patients being tested… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
